Sonova Holding (OTCMKTS:SONVY) Sees Significant Drop in Short Interest

Sonova Holding (OTCMKTS:SONVYGet Free Report) was the recipient of a large decline in short interest in the month of June. As of June 30th, there was short interest totaling 858 shares, a decline of 74.8% from the June 15th total of 3,402 shares. Currently, 0.0% of the shares of the company are sold short. Based on an average daily volume of 54,140 shares, the short-interest ratio is currently 0.0 days.

Analyst Ratings Changes

Several equities research analysts have commented on SONVY shares. Citigroup restated a “sell” rating on shares of Sonova in a research note on Wednesday, May 13th. Morgan Stanley upgraded Sonova from an “underweight” rating to an “equal weight” rating in a research report on Tuesday, June 23rd. Finally, Jefferies Financial Group lowered Sonova from a “hold” rating to a “moderate sell” rating in a report on Wednesday, March 18th. Two investment analysts have rated the stock with a Strong Buy rating, one has assigned a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy”.

View Our Latest Research Report on SONVY

Sonova Trading Down 0.2%

Shares of OTCMKTS SONVY traded down $0.12 during midday trading on Friday, reaching $50.24. 10,572 shares of the company traded hands, compared to its average volume of 20,820. The stock has a 50-day moving average price of $49.38 and a 200 day moving average price of $49.81. Sonova has a 52 week low of $42.26 and a 52 week high of $61.09. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.75 and a quick ratio of 1.43.

Sonova Company Profile

(Get Free Report)

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.

Featured Stories

Receive News & Ratings for Sonova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonova and related companies with MarketBeat.com's FREE daily email newsletter.